Inhibition of the tyrosine phosphatase STEP61 restores BDNF expression and reverses motor and cognitive deficits in phencyclidine-treated mice

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cellular and Molecular Life Sciences

• Publication date

  2015-10-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00018-015-2057-1PMID 26450419PMCID PMC4801664
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review.

  2015cited by this paper
• Striatal‐enriched protein tyrosine phosphatase regulates the PTPα/Fyn signaling pathway

  2015cited by this paper
• STEP61 is a substrate of the E3 ligase parkin and is upregulated in Parkinson’s disease

  2015cited by this paper
• Alterations in STriatal‐Enriched protein tyrosine Phosphatase expression, activation, and downstream signaling in early and late stages of the YAC128 Huntington's disease mouse model

  2014cited by this paper
• Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder

  2014cited by this paper
• Inhibitor of the Tyrosine Phosphatase STEP Reverses Cognitive Deficits in a Mouse Model of Alzheimer's Disease

  2014cited by this paper
• Small-molecule TrkB agonist 7,8-dihydroxyflavone reverses cognitive and synaptic plasticity deficits in a rat model of schizophrenia.

  2014cited by this paper
• Phencyclidine rapidly decreases neuronal mRNA of brain‐derived neurotrophic factor

  2014cited by this paper
• Essential role of presynaptic NMDA receptors in activity-dependent BDNF secretion and corticostriatal LTP.

  2014cited by this paper
• Elevation of BDNF Exon I-Specific Transcripts in the Frontal Cortex and Midbrain of Rat During Spontaneous Morphine Withdrawal is Accompanied by Enhanced pCreb1 Occupancy at the Corresponding Promoter

  2014cited by this paper
• Downstream effects of striatal-enriched protein tyrosine phosphatase reduction on RNA expression in vivo and in vitro.

  2014cited by this paper
• Transcriptomic analysis of genetically defined autism candidate genes reveals common mechanisms of action

  2013cited by this paper
• Phencyclidine-induced decrease of synaptic connectivity via inhibition of BDNF secretion in cultured cortical neurons.

  2013cited by this paper
• Striatal-enriched protein tyrosine phosphatase-STEPs toward understanding chronic stress-induced activation of corticotrophin releasing factor neurons in the rat bed nucleus of the stria terminalis.

  2013cited by this paper
• Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington's disease.

  2013cited by this paper
• Striatal-enriched Protein-tyrosine Phosphatase (STEP)

  2012cited by this paper
• GABAA Receptor Blockade Enhances Memory Consolidation by Increasing Hippocampal BDNF Levels

  2012cited by this paper
• Striatal-enriched Protein-tyrosine Phosphatase (STEP) Regulates Pyk2 Kinase Activity*

  2012cited by this paper
• Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model

  2012cited by this paper
• 7,8‐dihydroxyflavone rescues spatial memory and synaptic plasticity in cognitively impaired aged rats

  2012cited by this paper
• Molecular validation of the acute phencyclidine rat model for schizophrenia: identification of translational changes in energy metabolism and neurotransmission.

  2012cited by this paper
• Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders

  2012cited by this paper
• Therapeutic Implications for Striatal-Enriched Protein Tyrosine Phosphatase (STEP) in Neuropsychiatric Disorders

  2012cited by this paper
• The tyrosine phosphatase STEP: implications in schizophrenia and the molecular mechanism underlying antipsychotic medications

  2012cited by this paper
• Involvement of PTPN5, the gene encoding the striatal-enriched protein tyrosine phosphatase, in schizophrenia and cognition

  2012cited by this paper
• Dynamic O-GlcNAc Modification Regulates CREB-Mediated Gene Expression and Memory Formation

  2011cited by this paper
• Striatal-Enriched Protein Tyrosine Phosphatase Expression and Activity in Huntington's Disease: A STEP in the Resistance to Excitotoxicity

  2011cited by this paper
• Identification of cis-Elements and Transcription Factors Regulating Neuronal Activity-Dependent Transcription of Human BDNF Gene

  2011cited by this paper
• Regulation of Brain-Derived Neurotrophic Factor Exon IV Transcription through Calcium Responsive Elements in Cortical Neurons

  2011cited by this paper
• Animal models of schizophrenia

  2011cited by this paper
• Cocaine-Induced Chromatin Remodeling Increases Brain-Derived Neurotrophic Factor Transcription in the Rat Medial Prefrontal Cortex, Which Alters the Reinforcing Efficacy of Cocaine

  2010cited by this paper
• A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone

  2010cited by this paper
• Aβ-Mediated NMDA Receptor Endocytosis in Alzheimer's Disease Involves Ubiquitination of the Tyrosine Phosphatase STEP61

  2010cited by this paper
• Postsynaptic BDNF‐TrkB signaling in synapse maturation, plasticity, and disease

  2010cited by this paper
• Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism.

  2010cited by this paper
• Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer’s disease mouse model

  2010cited by this paper
• Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics

  2010cited by this paper
• Autophosphorylated CaMKIIalpha acts as a scaffold to recruit proteasomes to dendritic spines.

  2010cited by this paper
• Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia.

  2010cited by this paper
• An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies.

  2010cited by this paper
• TrkB signalling pathways in LTP and learning

  2009cited by this paper
• Knockout of STriatal enriched protein tyrosine phosphatase in mice results in increased ERK1/2 phosphorylation

  2009cited by this paper
• Repeated antipsychotic treatment progressively potentiates inhibition on phencyclidine-induced hyperlocomotion, but attenuates inhibition on amphetamine-induced hyperlocomotion: relevance to animal models of antipsychotic drugs.

  2009influential reference
• BDNF-induced synaptic delivery of AMPAR subunits is differentially dependent on NMDA receptors and requires ERK.

  2009cited by this paper
• The Tyrosine Phosphatase STEP Mediates AMPA Receptor Endocytosis after Metabotropic Glutamate Receptor Stimulation

  2008cited by this paper
• LUTAMATE STIMULATES GLUTAMATE RECEPTOR INTERACTING ROTEIN 1 DEGRADATION BY UBIQUITIN-PROTEASOME SYSTEM TO EGULATE SURFACE EXPRESSION OF GluR2

  2007cited by this paper
• Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors.

  2007cited by this paper
• Differential activation of CREB by Ca^^/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity

  2007cited by this paper
• Glutamate stimulates glutamate receptor interacting protein 1 degradation by ubiquitin-proteasome system to regulate surface expression of GluR2.

  2007cited by this paper
• Brain-derived neurotrophic factor rapidly increases NMDA receptor channel activity through Fyn-mediated phosphorylation.

  2006cited by this paper
• Neurobiology of schizophrenia.

  2006cited by this paper
• Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia

  2005cited by this paper
• The yin and yang of neurotrophin action

  2005cited by this paper
• Regulation of NMDA receptor trafficking by amyloid-beta.

  2005cited by this paper
• Regulation of NMDA receptor trafficking by amyloid-β

  2005cited by this paper
• NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling

  2003cited by this paper
• Striatal Enriched Phosphatase 61 Dephosphorylates Fyn at Phosphotyrosine 420*

  2002cited by this paper
• Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia.

  2002cited by this paper
• Dynamic multiphosphorylation passwords for activity-dependent gene expression.

  2002cited by this paper
• Developmental and stress-related changes of neurotrophic factor gene expression in an animal model of schizophrenia

  2001cited by this paper
• Distinct effects of cAMP and mitogenic signals on CREB-binding protein recruitment impart specificity to target gene activation via CREB

  2001cited by this paper
• Synaptic secretion of BDNF after high‐frequency stimulation of glutamatergic synapses

  2001cited by this paper
• Activity-Dependent Transfer of Brain-Derived Neurotrophic Factor to Postsynaptic Neurons

  2001cited by this paper
• Neurobiology of schizophrenia

  2000cited by this paper
• Molecular mechanisms underlying activity-dependent regulation of BDNF expression.

  1999cited by this paper
• Dysregulation of mesoprefrontal dopamine neurons induced by acute and repeated phencyclidine administration in the nonhuman primate: implications for schizophrenia.

  1998cited by this paper
• Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine.

  1997cited by this paper
• STEP61: A Member of a Family of Brain-Enriched PTPs Is Localized to the Endoplasmic Reticulum

  1996cited by this paper
• Cellular and molecular characterization of a brain-enriched protein tyrosine phosphatase

  1995cited by this paper
• Differential activation of CREB by Ca2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity.

  1994cited by this paper
• Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

  1994cited by this paper
• A protein tyrosine phosphatase expressed within dopaminoceptive neurons of the basal ganglia and related structures

  1993cited by this paper
• Multiple promoters direct tissue-specific expression of the rat BDNF gene.

  1993cited by this paper

• Lack of striatal-enriched protein tyrosine phosphatase affected the serotonin system, behavior, and brain morphology in mice

  2026cites this paper
• Current Concepts of the Role of Striatal-Enriched Protein Tyrosine Phosphatase STEP in the Pathological and Neurodegenerative Processes in the Brain

  2024cites this paper
• Current Concepts of the Role of the STEP Striatal-Enriched Protein Tyrosine Phosphatase in the Pathological and Neurodegenerative Processes in the Brain

  2024cites this paper
• Abnormal phosphorylation of protein tyrosine in neurodegenerative diseases.

  2023cites this paper
• On Associations between Fear-Induced Aggression, Bdnf Transcripts, and Serotonin Receptors in the Brains of Norway Rats: An Influence of Antiaggressive Drug TC-2153

  2023cites this paper
• Inhibition of Striatal-Enriched Protein Tyrosine Phosphatase (STEP) Activity Reverses Behavioral Deficits in a Rodent Model of Autism

  2020cites this paper
• Alterations of STEP46 and STEP61 Expression in the Rat Retina with Age and AMD-Like Retinopathy Development

  2020cites this paper
• New type of anti-influenza agents based on benzo[d][1,3]dithiol core.

  2020cites this paper
• The activity of the Striatal‐enriched protein tyrosine phosphatase in neuronal cells is modulated by adenosine A2A receptor

  2020cites this paper
• Disruption of Striatal-Enriched Protein Tyrosine Phosphatase Signaling Might Contribute to Memory Impairment in a Mouse Model of Sepsis-Associated Encephalopathy

  2019cites this paper
• Inhibitor of Striatal-Enriched Protein Tyrosine Phosphatase, 8-(Trifluoromethyl)-1,2,3,4,5-Benzopentathiepin-6-Amine hydrochloride (TC-2153), Produces Antidepressant-Like Effect and Decreases Functional Activity and Protein Level of 5-HT2A Receptor in the Brain.

  2018cites this paper
• The Tyrosine Phosphatase STEP Is Involved in Age-Related Memory Decline.

  2018cites this paper
• Huntington’s disease: novel therapeutic perspectives hanging in the balance

  2018cites this paper
• Intra‐prelimbic cortical inhibition of striatal‐enriched tyrosine phosphatase suppresses cocaine seeking in rats

  2018influential citation
• STEP inhibition reverses behavioral, electrophysiologic, and synaptic abnormalities in Fmr1 KO mice

  2018cites this paper
• Pharmacogenetic modulation of STEP improves motor and cognitive function in a mouse model of Huntington's disease.

  2018cites this paper
• Allosteric Activation of Striatal-Enriched Protein Tyrosine Phosphatase (STEP, PTPN5) by a Fragment-like Molecule.

  2018cites this paper
• Molecular and Supramolecular Structure of 8-(Trifluoromethyl)Benzo[f][1,2,3,4,5] Pentathiepin-6-Amine – A Representative of Condensed Arene Pentathiepines

  2018cites this paper
• Striatal-enriched Tyrosine Protein Phosphatase (STEP) in the Mechanisms of Depressive Disorders.

  2017cites this paper
• Antidepressant Actions of Ketamine Mediated by the Mechanistic Target of Rapamycin, Nitric Oxide, and Rheb

  2017cites this paper
• Covalent inhibition of protein tyrosine phosphatases.

  2017cites this paper
• Targeting Tyrosine Phosphatases: Time to End the Stigma.

  2017cites this paper
• Synaptic NMDA Receptor Activation Induces Ubiquitination and Degradation of STEP61

  2017cites this paper
• Inhibition of STEP61 ameliorates deficits in mouse and hiPSC-based schizophrenia models

  2016cites this paper